Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
other: case reports
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
review article or handbook
Title:
SIDS Initial Assessment Report for SIAM 18 for Adipic acid
Author:
OECD/SIDS
Year:
2004
Bibliographic source:
published by UNEP
Report date:
2004

Materials and methods

Type of sensitisation studied:
respiratory
skin
Study type:
case report
Principles of method if other than guideline:
no guideline followed

Test material

Constituent 1
Chemical structure
Reference substance name:
Adipic acid
EC Number:
204-673-3
EC Name:
Adipic acid
Cas Number:
124-04-9
Molecular formula:
C6H10O4
IUPAC Name:
adipic acid
Constituent 2
Reference substance name:
Hexanedioic acid
IUPAC Name:
Hexanedioic acid
Details on test material:
Purity is 99.8%

Method

Type of population:
occupational

Results and discussion

Results of examinations:
Despite the wide use of adipic acid, only very few cases of skin or respiratory tract reactions are reported:

A positive patch test reaction to adipic acid (probably 1 % in alcoholic solution) was reported in a 51-year-old machine repairman with a 3- to 4-year history of work-related dermatitis of the hands and other exposed sites when working with powders in the synthesis of polyesters (Guin 2001).
Delayed cutaneous hypersensitivity to adipic acid was reported in a patch test (100 %) with a laboratory worker in a factory producing polyester resins. No further details are available in this case (Malten and Zielhuis 1964).
Two cases of bronchial asthma were reported in workers of a pharmaceutical factory coming into contact with spiramycin adipate powder. One of the workers developed an immediate asthmatic reaction also after inhalation of an aerosolized solution (10 mg/ml) of adipic acid. The reaction was reproducible and inhibited by previous administration of sodium cromoglycate. These findings suggested a hypersensitivity reaction to adipic acid by this patient (Moscato et al. 1984).

Applicant's summary and conclusion